CARsgen Therapeutics Holdings Limited logo

CARsgen Therapeutics Holdings Limited

HKEX:2171.HK

Overview | Financials
Company Name CARsgen Therapeutics Holdings Limited
Symbol 2171.HK
Currency HKD
Price 3.08
Market Cap 1,543,860,660
Dividend Yield 0%
52-week-range 2.48 - 11.88
Industry Biotechnology
Sector Healthcare
CEO Dr. Zonghai Li M.D., Ph.D.
Website https://www.carsgen.com

An error occurred while fetching data.

About CARsgen Therapeutics Holdings Limited

CARsgen Therapeutics Holdings Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies and solid tumors in China and the United States. The company is involved in developing CT053, an autologous CAR-T product candidate that is in

Related Stocks

China Isotope & Radiation Corporation logo

China Isotope & Radiation Corporation

1763.HK

9.59 HKD

Beijing Chunlizhengda Medical Instruments Co., Ltd. logo

Beijing Chunlizhengda Medical Instruments Co., Ltd.

1858.HK

12.7 HKD

CK Life Sciences Int'l., (Holdings) Inc. logo

CK Life Sciences Int'l., (Holdings) Inc.

0775.HK

0.355 HKD

Keymed Biosciences Inc. logo

Keymed Biosciences Inc.

2162.HK

37.85 HKD

Alphamab Oncology logo

Alphamab Oncology

9966.HK

2.53 HKD

Brii Biosciences Limited logo

Brii Biosciences Limited

2137.HK

0.93 HKD

Medlive Technology Co., Ltd. logo

Medlive Technology Co., Ltd.

2192.HK

7.65 HKD

SciClone Pharmaceuticals (Holdings) Limited logo

SciClone Pharmaceuticals (Holdings) Limited

6600.HK

18.72 HKD

Everest Medicines Limited logo

Everest Medicines Limited

1952.HK

22.9 HKD

The United Laboratories International Holdings Limited logo

The United Laboratories International Holdings Limited

3933.HK

8.39 HKD

Financials

Numbers are in millions USD

Numbers are in millions USD